MAPS Bulletin Autumn 1994 Vol. 05, No. 2 Building Towards Clinical Trials
MAPS received a $2,000 grant to support the research of Dr. Evgeny Krupitsky, a Russian scientist who uses ketamine in the treatment of alcoholics and neurotics. Since Dr. Krupitsky already has published scientific papers describing his positive results (which have been discussed in past issues of the MAPS newsletter), the next step in the scientific process is for other researchers to try to replicate his findings. Therefore, MAPS is sponsoring a visit to the United States by Dr. Krupitsky in late January and early February, 1995.
Dr. Krupitsky will visit Albuquerque, New Mexico in order to work with Dr. Rick Strassman, who is actively researching DMT and psilocybin. He will also visit Los Angeles to meet with Dr. Charles Grob, who is conducting MDMA research. Another stop will be Baltimore to meet with Richard Yensen, Ph.D. and Dr. Donna Dryer, who are planning to study the use of LSD in the treatment of substance abuse. While in Baltimore, MAPS will also try to arrange for Dr. Krupitsky to visit with officials at NIDA’s Medications Development Division, which is investigating the use of ibogaine in the treatment of cocaine and heroin addiction.
Dr. Krupitsy will also visit Miami to meet with Dr. Sanchez-Ramos and Deborah Mash, Ph.D., who are conducting the first safety studies with ibogaine. Finally, Dr. Krupitksy will visit Tampa to meet Dr. Eli Kolp, a psychiatrist who immigrated to the US from Russia and is interested in investigating ketamine in the treatment of alcoholism.
If any MAPS readers would be interested in meeting Dr. Krupitsky during his travels, please let the MAPS office know and we will try to make the necessary arrangements.
